Dec 3 2024 - U.S. District Court Upholds Validity of CINVANTI® Patents
Nov 12 2024 - Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows...
Nov 4 2024 - Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors...
Oct 29 2024 - Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday,...